June 20, 2016
June 20, 2016 —
Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.
June 10, 2016
June 10, 2016 —
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint.
June 9, 2016
June 9, 2016 —
The University of California San Diego School of Medicine has launched the Institute for Diabetes and Metabolic Health (IDMH), a new cross-disciplinary, collaborative effort to address one of the nation’s leading public health threats.
June 9, 2016
June 9, 2016 —
Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors. Researchers at University of California San Diego School of Medicine have now unraveled how pre-leukemic white blood cell precursors become leukemia stem cells.
June 7, 2016
June 7, 2016 —
Excitement was palpable at UC San Diego’s inaugural Triton Entrepreneur Night as student entrepreneurs, alumni, staff, and community supporters gathered for demos and presentations from the latest crop of student-driven innovations.
June 7, 2016
June 7, 2016 —
Students and researchers at all stages of their academic careers went head-to-head recently, competing for $100k in prizes at the 10th annual UC San Diego Entrepreneur Challenge.
June 6, 2016
June 6, 2016 —
To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph “pan-genome” — the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published June 6 by PNAS, places all Staph genes into one of two categories: the core genome or the dispensable genome.
June 6, 2016
June 6, 2016 —
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
June 6, 2016
June 6, 2016 —
Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a 5-year survival rate of just 6 percent. In a new study, researchers at University of California San Diego School of Medicine and Moores Cancer Center, together with colleagues at Keio University, the University of Nebraska and Ionis Pharmaceuticals describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target.
June 2, 2016
June 2, 2016 —
University of California San Diego School of Medicine researchers are expanding the
American Gut Project into Asia. The goal of American Gut, the world’s largest crowdfunded citizen science project, is to sequence as many human microbiomes — the unique collection of bacteria and other microbes that live in and on us — as possible.
